PCV7


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.
Related to PCV7: Polio vaccine

PCV7

An abbreviation for a pneumococcal polyvalent vaccine with antigens from seven common serotypes of Streptococcus pneumoniae. It is used, like PCV13, to immunize children against pneumococcal diseases, e.g., otitis media, pneumonia, meningitis.
References in periodicals archive ?
In February 2010, the vaccination incentive for PCV7 in children began on a voluntary basis.
14] recently demonstrated that after the introduction of PCV7 vaccination, if antibiotic prescribing remained high (particularly cephalosporins and long-acting macrolides/azalides), the proportion of non-susceptible invasive pneumococcal disease due to non-vaccine serotypes also remained high, suggesting that local prescribing practices continue to contribute to local resistance patterns.
The cumulative frequency by age at 1st, 2nd, 3rd and 4th PCV7 dose is shown in Figure 2.
Two polysaccharide-protein conjugate vaccines are currently part of the routine immunisation programme in South Africa: Hib (Haemophilus influenzae serotype b) and PCV7 (7-valent pneumococcal conjugate vaccine
Overall PCV10-7 IPD incidence increased slightly after PCV7 introduction (CIR 1.
29 Consequently in the USA, universal immunisation of children with PCV7 has been estimated to directly reduce the number of cases of IPD by approximately 9 000 among vaccinated children, while indirect protection resulted in a further 20 000 cases of IPD being prevented per year.
Key uses and findings of Active Bacterial Core surveillance data for vaccine development, evaluation, and policy formulation * Pathogen Vaccines Streptococcus pneumoniae PCV7 and PCV13 Neisseria meningitidis Conjugate vaccines, serogroup B vaccines Haemophilus influenzae Hib vaccine Group A Streptococcus M-type vaccine (under development) Group B Streptococcus Trivalent vaccine (under development) Methicillin-resistant S.
A postal questionnaire was sent to parents, who were asked to provide dates of administration of PCV7 as recorded in the child's immunization chart.
The EIPs conducted a case-control study of PCV7 effectiveness during 2001-2003 and ultimately enrolled 782 case-patients and 2,512 controls (14).
Bunun yaninda PCV7 pnomoni, otitis media ve sinuzit gibi mukozal enfeksiyonlara karsi da etkilidir (5-8).
Wyeth applauds the countries of Cyprus, Hungary, the Kingdom of Bahrain, Republic of Ireland, Slovak Republic and Sweden for announcing their decisions to routinely immunize infants and young children against pneumococcal disease by adding PREVENAR(TM) PCV7 (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed) to their national immunization programs(1).
Children aged 24-59 months should receive PCV7 vaccination if they have or are scheduled to receive a cochlear implant.